Position in LH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,093,840
+$164,004 QoQ
Shares Held
7,478
+3.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#368
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GUGGENHEIM CAPITAL LLC holds $87,241,882 across 22 Diagnostics & Research names. LH ranks #10 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
38,241 | $19,172,506 | |
| 2 | DHR |
Danaher Corp /De/
|
74,903 | $14,267,522 | |
| 3 | GH |
Guardant Health, Inc.
|
73,753 | $11,065,162 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
20,242 | $10,656,198 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
36,111 | $6,977,366 | |
| 6 | ILMN |
Illumina, Inc.
|
37,140 | $6,530,325 | |
| 7 | NTRA |
Natera, Inc.
|
12,633 | $3,429,227 | |
| 8 | WAT |
Waters Corp /De/
|
6,822 | $2,558,522 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,093,840 | 7,478 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,929,836 | 7,233 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,400,160 | 5,581 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,689,059 | 5,884 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,763,541 | 6,718 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,552,374 | 6,670 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,698,802 | 7,408 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,565,476 | 7,005 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,305,109 | 6,413 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||